Cite
HARVARD Citation
Westin, J. et al. (2023). Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma. Journal of clinical oncology. 41 (4), pp. 745-755. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Westin, J. et al. (2023). Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma. Journal of clinical oncology. 41 (4), pp. 745-755. [Online].